Invivyd, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| MCLAUGHLIN KEVIN F | — | Purchase | 50,000 | $2.50 | $125,000 | 50,000 | Nov 19, 2025 |
| Lee Timothy Edward | Chief Commercial Officer | Sale | 20,013 | $0.65 | $13,008 | 88,987 | Aug 19, 2025 |
| Duke William E. | Chief Financial Officer | Sale | 20,013 | $0.65 | $13,008 | 78,987 | Aug 19, 2025 |
| Allen Robert D. III | Chief Scientific Officer | Option Exercise | 99,000 | — | — | 99,000 | Aug 19, 2025 |
| Andersen Jill | Chief Legal Officer, Secretary | Option Exercise | 165,000 | — | — | 167,200 | Aug 18, 2025 |
| Green Julie | Chief Human Resources Officer | Sale | 29,643 | $0.57 | $16,897 | 49,344 | Aug 15, 2025 |
| MCGUIRE TERRANCE | — | Sale | 103,474 | $0.45 | $46,563 | 3,066,757 | Dec 30, 2024 |
| MCGUIRE TERRANCE | — | Sale | 119,805 | $0.42 | $50,318 | 3,568,274 | Dec 24, 2024 |
| MCGUIRE TERRANCE | — | Sale | 97,410 | $0.48 | $46,757 | 3,914,910 | Dec 19, 2024 |
| MCGUIRE TERRANCE | — | Sale | 125,000 | $0.58 | $72,500 | 4,077,679 | Dec 16, 2024 |
| MCGUIRE TERRANCE | — | Sale | 175,000 | $0.59 | $103,250 | 4,363,079 | Dec 11, 2024 |
| MCGUIRE TERRANCE | — | Sale | 112,381 | $1.66 | $186,552 | 4,688,079 | May 29, 2024 |
| Adimab, LLC | — | Sale | 5,000,000 | $3.95 | $19,750,000 | 21,687,906 | Jan 19, 2024 |
| Hering David | Chief Executive Officer | Purchase | 8,000 | $4.52 | $36,160 | 8,000 | Sep 1, 2022 |
| Elia Marc | — | Purchase | 1,265,549 | $4.31 | $5,454,516 | 8,663,799 | Aug 19, 2022 |
| Adimab, LLC | — | Other | 1,158,089 | — | — | 26,687,906 | Mar 3, 2022 |
| Redmile Group, LLC | — | Purchase | 1,470,000 | $17.00 | $24,990,000 | 3,390,960 | Aug 10, 2021 |
| Adimab, LLC | — | C | 25,860,700 | — | — | 27,845,995 | Aug 10, 2021 |
| Gerngross Tillman U. | Chief Executive Officer | C | 25,860,700 | — | — | 27,845,995 | Aug 10, 2021 |
| MCGUIRE TERRANCE | — | Purchase | 267,769 | $17.00 | $4,552,073 | 3,120,194 | Aug 10, 2021 |
| Mithril II UGP LLC | — | Purchase | 1,997,000 | $17.00 | $33,949,000 | 11,241,580 | Aug 10, 2021 |
| Royan Ajay | — | Purchase | 1,997,000 | $17.00 | $33,949,000 | 11,241,580 | Aug 10, 2021 |